Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...

Is Hims & Hers a millionaire-maker in the making? Yes! Or, at least, it can be. There is a possible future where Hims & Hers ...

Before Hims & Hers' commercial even aired ... "help-seeking" advertisements." The day after the ad for Hims & Hers' aired during the Super Bowl, on Feb. 10, Novo Nordisk, the maker of Ozempic ...

And the company’s share price is up about 15% since just before the Super Bowl, giving it a valuation of more than $10 billion. Hims & Hers may be taking risks and pushing the regulatory ...

Hims & Hers has shown impressive revenue growth ... followed by 0% for the 12 months after that. For years 3, 4 and 5 we assume a growth rate of 20-25%. We assume that Hims’ weight loss business ...

Share on Pinterest Hers, a part of the Hims & Hers Health platform ... The prescription-only products are available after signing up for the service and completing the questionnaire.

By contrast, Novo Nordisk is both the developer and seller of Wegovy, while Viking Therapeutics's VK2735 has posted impressive results in testing and is now in the later stages of development. Wegovy ...

Telehealth company Hims & Hers Health is fighting back after the drug industry’s main lobbying group called out its first Super Bowl ad as “misleading” and in potential violation of ...

After telehealth brand ... The “Check before you inject” ad specifically calls out compounded medications, which is the type that Hims & Hers manufactures and is not FDA approved.